Physician profile
Laurence Ehrlich
NPI 1508823402
$4,673.85
in general payments reported to CMS, 2019-2025
40 companies · $1,113 in 2025
The $1,113 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $324 · 2020: $294 · 2021: $277 · 2022: $676 · 2023: $822 · 2024: $1,167 · 2025: $1,113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,102.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $792.08 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $431.72 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $419.33 | 2019-2025 | |
| Novo Nordisk INC | $309.61 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Amgen INC. | $292.82 | 2019-2025 | Repatha, Otezla, Otezla |
| Abbott Laboratories | $238.45 | 2021-2025 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $228.55 | 2022-2024 | Jardiance |
| Exact Sciences Corporation | $211.33 | 2023-2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $209.44 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amarin Pharma, INC. | $147.92 | 2020-2022 | |
| Abbvie INC. | $129.59 | 2021-2025 | |
| Progenics Pharmaceuticals, INC. | $127.47 | 2022 | |
| Novartis Pharmaceuticals Corporation | $112.99 | 2022-2023 | |
| Edwards Lifesciences Corporation | $112.69 | 2023-2024 | |
| Horizon Therapeutics Plc | $94.83 | 2023 | Actimmune |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurence Ehrlich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.